Literature DB >> 20421386

Role of high-mobility group box 1 protein and poly(ADP-ribose) polymerase 1 degradation in Chlamydia trachomatis-induced cytopathicity.

Hangxing Yu1, Katja Schwarzer, Martin Förster, Olaf Kniemeyer, Vera Forsbach-Birk, Eberhard Straube, Jürgen Rödel.   

Abstract

As intracellular bacteria, chlamydiae block the apoptotic pathways of their host cells. However, the infection of epithelial cells causes the loss of cell membrane integrity and can result in nonapoptotic death. Normally, cells undergoing necrosis release high-mobility group box 1 protein (HMGB1) that acts as an important proinflammatory mediator. Here, we show that in Chlamydia trachomatis-infected HeLa cells HMGB1 is not translocated from the nucleus to the cytosol and not released from injured cells in increased amounts. At 48 h after infection, degradation of HMGB1 was observed. In infected cells, poly(ADP-ribose) polymerase 1 (PARP-1), a DNA repair enzyme that also regulates HMGB1 translocation, was found to be cleaved into fragments that correspond to a necrosis like pattern of PARP-1 degradation. Cell-free cleavage assays and immunoprecipitation using purified proteolytic fractions from infected cells demonstrated that the chlamydial-protease-like activity factor (CPAF) is responsible for the cleavage of both HMGB1 and PARP-1. Proteolytic cleavage of PARP-1 was accompanied by a significant decrease in the enzymatic activity in a time-dependent manner. The loss of PARP-1 function obviously affects the viability of Chlamydia-infected cells because silencing of PARP-1 in uninfected HeLa cells with specific small interfering RNA results in increased cell membrane permeability. Our findings suggest that the Chlamydia-specific protease CPAF interferes with necrotic cell death pathways. By the degradation of HMGB1 and PARP-1, the pathogen may have evolved a strategy to reduce the inflammatory response to membrane-damaged cells in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20421386      PMCID: PMC2897395          DOI: 10.1128/IAI.01404-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

Review 1.  More than one way to die: apoptosis, necrosis and reactive oxygen damage.

Authors:  W Fiers; R Beyaert; W Declercq; P Vandenabeele
Journal:  Oncogene       Date:  1999-12-16       Impact factor: 9.867

2.  Role of Bcl-2 family members in caspase-independent apoptosis during Chlamydia infection.

Authors:  Jean-Luc Perfettini; John C Reed; Nicole Israël; Jean-Claude Martinou; Alice Dautry-Varsat; David M Ojcius
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

3.  Characterization of antiapoptotic activities of Chlamydia pneumoniae in human cells.

Authors:  S F Fischer; C Schwarz; J Vier; G Häcker
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

4.  Characterization of the necrotic cleavage of poly(ADP-ribose) polymerase (PARP-1): implication of lysosomal proteases.

Authors:  S Gobeil; C C Boucher; D Nadeau; G G Poirier
Journal:  Cell Death Differ       Date:  2001-06       Impact factor: 15.828

5.  Inhibition of host cell cytokinesis by Chlamydia trachomatis infection.

Authors:  Whitney Greene; Guangming Zhong
Journal:  J Infect       Date:  2003-07       Impact factor: 6.072

6.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation.

Authors:  Paola Scaffidi; Tom Misteli; Marco E Bianchi
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

7.  Protection against CD95-induced apoptosis by chlamydial infection at a mitochondrial step.

Authors:  Silke F Fischer; Thomas Harlander; Juliane Vier; Georg Häcker
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

Review 8.  PARP-1, a determinant of cell survival in response to DNA damage.

Authors:  Véronique J Bouchard; Michèle Rouleau; Guy G Poirier
Journal:  Exp Hematol       Date:  2003-06       Impact factor: 3.084

9.  Identification and evaluation of a combination of chlamydial antigens to support the diagnosis of severe and invasive Chlamydia trachomatis infections.

Authors:  V Forsbach-Birk; U Simnacher; K-I Pfrepper; E Soutschek; A O Kiselev; M F Lampe; T Meyer; E Straube; A Essig
Journal:  Clin Microbiol Infect       Date:  2009-09-01       Impact factor: 8.067

10.  Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors.

Authors:  G Zhong; P Fan; H Ji; F Dong; Y Huang
Journal:  J Exp Med       Date:  2001-04-16       Impact factor: 14.307

View more
  16 in total

Review 1.  Location is the key to function: HMGB1 in sepsis and trauma-induced inflammation.

Authors:  Meihong Deng; Melanie J Scott; Jie Fan; Timothy R Billiar
Journal:  J Leukoc Biol       Date:  2019-04-04       Impact factor: 4.962

2.  The Chlamydia protease CPAF regulates host and bacterial proteins to maintain pathogen vacuole integrity and promote virulence.

Authors:  Ine Jorgensen; Maria M Bednar; Vishar Amin; Beckley K Davis; Jenny P Y Ting; Dewey G McCafferty; Raphael H Valdivia
Journal:  Cell Host Microbe       Date:  2011-07-21       Impact factor: 21.023

Review 3.  Exploring NAD+ metabolism in host-pathogen interactions.

Authors:  Inês Mesquita; Patrícia Varela; Ana Belinha; Joana Gaifem; Mireille Laforge; Baptiste Vergnes; Jérôme Estaquier; Ricardo Silvestre
Journal:  Cell Mol Life Sci       Date:  2015-12-30       Impact factor: 9.261

4.  Persistent Chlamydia trachomatis infection of HeLa cells mediates apoptosis resistance through a Chlamydia protease-like activity factor-independent mechanism and induces high mobility group box 1 release.

Authors:  Jürgen Rödel; Christina Grosse; Hangxing Yu; Katharina Wolf; Gordon P Otto; Elisabeth Liebler-Tenorio; Vera Forsbach-Birk; Eberhard Straube
Journal:  Infect Immun       Date:  2011-10-24       Impact factor: 3.441

Review 5.  Beyond DNA repair, the immunological role of PARP-1 and its siblings.

Authors:  Maria Manuela Rosado; Elisabetta Bennici; Flavia Novelli; Claudio Pioli
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

6.  IL10 Promoter Polymorphisms are Associated with Rheumatic Heart Disease in Saudi Arabian Patients.

Authors:  Atiyeh M Abdallah; Aisha Alnuzha; Abdulhadi H Al-Mazroea; Amr E Eldardear; Ala Y AlSamman; Yousef Almohammadi; Khalid M Al-Harbi
Journal:  Pediatr Cardiol       Date:  2015-08-09       Impact factor: 1.655

Review 7.  Immune Cell Regulatory Pathways Unexplored as Host-Directed Therapeutic Targets for Mycobacterium tuberculosis: An Opportunity to Apply Precision Medicine Innovations to Infectious Diseases.

Authors:  Robert N Mahon; Richard Hafner
Journal:  Clin Infect Dis       Date:  2015-10-15       Impact factor: 9.079

Review 8.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

Review 9.  Chlamydial intracellular survival strategies.

Authors:  Robert J Bastidas; Cherilyn A Elwell; Joanne N Engel; Raphael H Valdivia
Journal:  Cold Spring Harb Perspect Med       Date:  2013-05-01       Impact factor: 6.915

10.  Reassessing the role of the secreted protease CPAF in Chlamydia trachomatis infection through genetic approaches.

Authors:  Emily A Snavely; Marcela Kokes; Joe Dan Dunn; Hector A Saka; Bidong D Nguyen; Robert J Bastidas; Dewey G McCafferty; Raphael H Valdivia
Journal:  Pathog Dis       Date:  2014-05-16       Impact factor: 3.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.